HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Workforce, practice challenges jeopardize ability to meet growing demands of cancer care
-
- Spirituality plays key role in patients’ cancer care Tracy Balboni, MD, MPH
- The state of the science: Starting a dialogue about HSCT William Wood, MD
- Pre-transplant imatinib improved clinical outcomes in Ph+ALL patients undergoing HSCT
- Use of brachytherapy for localized prostate cancer has declined
- Many older patients with glioblastoma face considerable hospitalization burden
- Anticoagulants plus NSAIDs or aspirin increased bleeding risk in VTE
- Aspirin improved survival in colon cancers expressing HLA class I antigen
- Bariatric surgery reduced uterine cancer risk by 71%
-
- Clofarabine plus cytarabine shows promise in pediatric AML
- Low-dose Z-100 extended OS in locally advanced cervical cancer
- Sorafenib extended PFS in advanced thyroid cancer
- Neoadjuvant carboplatin induced responses in triple-negative breast cancer
- Preventive oophorectomy in BRCA mutation carriers reduced cancer risk by 80%
- New chemotherapy combination improved OS in metastatic pancreatic cancer
- Urologic oncologist joins UCLA faculty
- Brain metastases in melanoma require multidisciplinary approach
-
- Nationwide screening would increase lung cancer detection as well as costs